Inovio Pharmaceuticals Inc (NASDAQ: INO) kicked off on Tuesday, down -12.33% from the previous trading day, before settling in for the closing price of $10.99. Over the past 52 weeks, INO has traded in a range of $3.89-$14.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 60.80% over the last five years. While this was happening, its average annual earnings per share was recorded 36.75%. With a float of $22.99 million, this company’s outstanding shares have now reached $23.37 million.
The firm has a total of 122 workers. Let’s measure their productivity.
Inovio Pharmaceuticals Inc (INO) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Inovio Pharmaceuticals Inc is 1.61%, while institutional ownership is 17.91%. The most recent insider transaction that took place on Jun 05 ’23, was worth 3,192. In this transaction Director of this company sold 5,700 shares at a rate of $0.56, taking the stock ownership to the 52,716 shares.
Inovio Pharmaceuticals Inc (INO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 36.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.50% during the next five years compared to 13.49% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Take a look at Inovio Pharmaceuticals Inc’s (INO) current performance indicators. Last quarter, stock had a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 271.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.11, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -3.02 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Analysing the last 5-days average volume posted by the [Inovio Pharmaceuticals Inc, INO], we can find that recorded value of 0.35 million was lower than the volume posted last year of 0.53 million. As of the previous 9 days, the stock’s Stochastic %D was 14.03%. Additionally, its Average True Range was 1.08.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 51.53%, which indicates a significant increase from 20.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.18% in the past 14 days, which was lower than the 104.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.82, while its 200-day Moving Average is $6.65. Now, the first resistance to watch is $10.45. This is followed by the second major resistance level at $11.26. The third major resistance level sits at $12.31. If the price goes on to break the first support level at $8.59, it is likely to go to the next support level at $7.54. Should the price break the second support level, the third support level stands at $6.73.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
The company with the Market Capitalisation of 225.17 million has total of 23,370K Shares Outstanding. Its annual sales at the moment are 830 K in contrast with the sum of -135,120 K annual income. Company’s last quarter sales were recorded 100 K and last quarter income was -25,000 K.
